Spinal muscular atrophy (SMA) is a genetic condition that weakens muscles throughout the body. This makes it difficult to move, swallow, and in some cases breathe. SMA is caused by a gene mutation ...
Spinal muscular atrophy (SMA) can cause weakness, difficulty controlling movements, and difficulty swallowing and breathing. It can be carried in certain genes. Spinal muscular atrophy (SMA) is a ...
As the feasibility of phase 1 clinical trials for prenatal spinal muscular atrophy (SMA) therapies is explored, patient and parent input on prenatal testing and possibly treatment is a valuable tool ...
Disease-specific statements are intended to augment the current general American College of Medical Genetics (ACMG) Standards and Guidelines for Clinical Genetic Laboratories. Individual laboratories ...
On September 30, 2009, the National Human Genome Research Institute, the Eunice Kennedy Shriver National Institute of Child Health and Human Development, and the National Institute of Neurological ...
CAMBRIDGE, Mass. and SAN FRANCISCO, Aug. 20, 2019 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) and Invitae Corporation (NYSE: NVTA) today announced that SMA STAT, a new, rapid-turnaround genetic ...
The Model IPP-3013 is a dual-directional 200-W coupler covering 100 to 1000 MHz in a 1.50- by 2.50-in. package with SMA connectors. A typical application for the coupler includes monitoring forward or ...